— medical cannabis research platform
Data doesn't care what you were told - it only asks whether you're ready to look Some questions deserve better answers than the ones you've been given. cannabishub is a research platform built on published science - designed for anyone who takes the evidence seriously.
articles
latest
Medical treatment of autism spectrum disorder in children: Current evidence, controversies, and clinical challenges
Abstract BACKGROUND: Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition associated with debilitating comorbidities [e.g., aggression, irritability, gastrointestinal (GI)…
Cannabidiol Protects Against 1‐Methyl‐4‐Phenylpyridinium and Manganese‐Induced Neurotoxicity via Nod‐Like Receptor Protein 3 Inflammasome Suppression
Abstract Parkinson’s disease (PD) is a neurodegenerative disorder characterized by dopaminergic neurodegeneration, alpha‐synuclein (α‐Syn) accumulation, and neuroinflammation. The NOD‐Like Receptor…
— The Project
One place.
All the evidence.
A structured research environment for medical cannabis. Peer-reviewed evidence from thousands of publications - aggregated, indexed, and made searchable through modern language processing. One entry point into the science that matters.
The groundwork is laid. The work continues.
Article types
- Brief Report
- Case Report
- Case Study
- Data Paper
- Methods Article
- Protocol
- Rapid Communication
- Research Article
- Review Article
- Systematic Review
Medical treatment of autism spectrum disorder in children: Current evidence, controversies, and clinical challenges
Abstract BACKGROUND: Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition associated with debilitating comorbidities [e.g., aggression, irritability, gastrointestinal (GI)…
Cannabidiol Protects Against 1‐Methyl‐4‐Phenylpyridinium and Manganese‐Induced Neurotoxicity via Nod‐Like Receptor Protein 3 Inflammasome Suppression
Abstract Parkinson’s disease (PD) is a neurodegenerative disorder characterized by dopaminergic neurodegeneration, alpha‐synuclein (α‐Syn) accumulation, and neuroinflammation. The NOD‐Like Receptor…
AB‐MDMSBA—Not a Synthetic Cannabinoid Receptor Agonist
Abstract Synthetic cannabinoids remain one of the most prominent classes of New Psychoactive Substances (NPS). The introduction of “blanket bans”…
Cannabis legalization in Europe
Status as of early 2026 — hover or click for details
Sources: EUDA 2025, Chambers & Partners, Cannigma, Dutch Passion. Data is indicative — verify with official national sources.
Knowledge Base · Browse by Relationship
What was studied with what
Explore connections between compounds and conditions across the research library. Pick a substance, pair it with one or more conditions — the article list narrows as you go.